HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical improvement in antiphospholipid syndrome after rituximab therapy.

AuthorsRosemary Adamson, Shirish Sangle, Arvind Kaul, Graham R V Hughes, David P D'Cruz
JournalJournal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases (J Clin Rheumatol) Vol. 14 Issue 6 Pg. 359-60 (Dec 2008) ISSN: 1536-7355 [Electronic] United States
PMID19033874 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antirheumatic Agents
  • Rituximab
Topics
  • Adult
  • Antibodies, Monoclonal (adverse effects, therapeutic use)
  • Antibodies, Monoclonal, Murine-Derived
  • Antiphospholipid Syndrome (drug therapy)
  • Antirheumatic Agents (adverse effects, therapeutic use)
  • Female
  • Humans
  • Rituximab
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: